| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.1 |